Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma
Hemasphere
.
2024 Mar 20;8(3):e61.
doi: 10.1002/hem3.61.
eCollection 2024 Mar.
Authors
George Mellgard
1
,
Molly Gilligan
1
,
Edward R Scheffer Cliff
2
,
Divaya Bhutani
3
,
Ghulam R Mohyuddin
4
,
Andrew Eisenberger
3
,
Suzanne Lentzsch
3
,
Rajshekhar Chakraborty
3
Affiliations
1
Department of Medicine Columbia University Irving Medical Center New York New York USA.
2
Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
3
Columbia University Herbert Irving Comprehensive Cancer Center New York New York USA.
4
University of Utah Salt Lake City Utah USA.
PMID:
38510991
PMCID:
PMC10951870
DOI:
10.1002/hem3.61
No abstract available